BAYLOR COLLEGE OF MEDICINE
Project 2: CAR-T cell therapy for T cell lymphoma
Project 2: CAR-T cell therapy for T cell lymphoma is a funding opportunity from BAYLOR COLLEGE OF MEDICINE, up to 1269725, closing August 31, 2027.
Aug 31, 2027
(396d left)Overview
PROJECT SUMMARY/ABSTRACT Aim 1: Determine the impact of incorporating dasatinib and ibrutinib into the manufacturing process of CD5 CAR T cells. The clinical trial has been completed, and a manuscript is in preparation. Aim 2: Develop and optimize a robust, non-alloreactive allogeneic CD5 CAR T-cell platform armed…